We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's 5 Medical Stocks Soaring After Earnings Today
Read MoreHide Full Article
Second-quarter earnings season may be wrapping up, but a plethora of companies in the medical industry were yet to report until this week. Several key drug, biotech, and medical instruments companies reported earnings on Monday and Tuesday, and there was a lot of good news to go around.
A quick glance at Tuesday’s biggest movers shows that many medical-related stocks are making big gains following earnings announcements. Check out these five companies that are in the green following their most recent reports:
OPKO Health is a multinational biopharmaceutical and diagnostics company. The company announced its earnings results after the closing bell Monday. OPKO beat out the Zacks Consensus Estimate, which called for a breakeven quarter, posting earnings of two cents per share. Quarterly revenues came in at $357 million, which crushed our consensus estimate of $31 million. The stock quickly popped nearly 4% in after-hours trading Monday before coming back down a bit Tuesday morning. Shares are currently up about 1.5% on the day.
ICU Medical, a leading supplier of disposable connections systems for use in intravenous therapies, also released its earnings report on Monday afternoon. The company posted earnings of 98 cents per share, which cruised past the Zacks Consensus Estimate of 89 cents. Quarterly revenues of $97 million also beat our estimate of $90 million. Shares of ICUI jumped over 5.5% in after-hours trading, and the stock is now up nearly 7% from Monday’s close.
Nevro Corp is a medical device company that develops neuromodulation platforms for the treatment of chronic pain. The company reported its earnings on Monday, posting a loss of 31 cents per share. The Zacks Consensus Estimate called for a loss of 46 cents per share. Nevro also posted revenue of $55.4 million, which beat our consensus estimate of $45 million. Shares of NVRO gained nearly 10% in after-hours trading and continued to climb Tuesday. The stock is up about 15% today.
4. Valeant Pharmaceuticals
Valeant Pharmaceuticals, the struggling pharma giant, released its second-quarter earnings report on Tuesday morning. Its EPS of $1.40 and revenue of $2.4 billion both missed our consensus estimates, but investors were encouraged by other aspects of the reports. Valeant announced a new “strategic vision” and affirmed its full-year guidance, which sent shares soaring. VRX gained over 18.5% in morning trading Tuesday.
5. Endo International plc
Endo International also announced its second-quarter earnings results on Tuesday morning, and the company also impressed investors. Endo reported earnings of 86 cents per share, beating the Zacks Consensus Estimate of 75 cents per share. The company also saw revenues of $920.9 million, which beat our estimate of $878.3 million. That revenue figure represents growth of 25% on a year-over-year basis, and Endo also affirmed its full-year guidance. Shares of ENDP gained over 22% in morning trading.
Bottom Line
For those who follow the Zacks Industry Rank, these earnings results will come as no surprise. Across the board, medical related industries have been impressive recently. Investors should continue to check out these sectors for other stocks that could post big gains.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's 5 Medical Stocks Soaring After Earnings Today
Second-quarter earnings season may be wrapping up, but a plethora of companies in the medical industry were yet to report until this week. Several key drug, biotech, and medical instruments companies reported earnings on Monday and Tuesday, and there was a lot of good news to go around.
A quick glance at Tuesday’s biggest movers shows that many medical-related stocks are making big gains following earnings announcements. Check out these five companies that are in the green following their most recent reports:
1. OPKO Health (OPK - Free Report)
OPKO Health is a multinational biopharmaceutical and diagnostics company. The company announced its earnings results after the closing bell Monday. OPKO beat out the Zacks Consensus Estimate, which called for a breakeven quarter, posting earnings of two cents per share. Quarterly revenues came in at $357 million, which crushed our consensus estimate of $31 million. The stock quickly popped nearly 4% in after-hours trading Monday before coming back down a bit Tuesday morning. Shares are currently up about 1.5% on the day.
2. ICU Medical Inc. (ICUI - Free Report)
ICU Medical, a leading supplier of disposable connections systems for use in intravenous therapies, also released its earnings report on Monday afternoon. The company posted earnings of 98 cents per share, which cruised past the Zacks Consensus Estimate of 89 cents. Quarterly revenues of $97 million also beat our estimate of $90 million. Shares of ICUI jumped over 5.5% in after-hours trading, and the stock is now up nearly 7% from Monday’s close.
3. Nevro Corp. (NVRO - Free Report)
Nevro Corp is a medical device company that develops neuromodulation platforms for the treatment of chronic pain. The company reported its earnings on Monday, posting a loss of 31 cents per share. The Zacks Consensus Estimate called for a loss of 46 cents per share. Nevro also posted revenue of $55.4 million, which beat our consensus estimate of $45 million. Shares of NVRO gained nearly 10% in after-hours trading and continued to climb Tuesday. The stock is up about 15% today.
4. Valeant Pharmaceuticals
Valeant Pharmaceuticals, the struggling pharma giant, released its second-quarter earnings report on Tuesday morning. Its EPS of $1.40 and revenue of $2.4 billion both missed our consensus estimates, but investors were encouraged by other aspects of the reports. Valeant announced a new “strategic vision” and affirmed its full-year guidance, which sent shares soaring. VRX gained over 18.5% in morning trading Tuesday.
5. Endo International plc
Endo International also announced its second-quarter earnings results on Tuesday morning, and the company also impressed investors. Endo reported earnings of 86 cents per share, beating the Zacks Consensus Estimate of 75 cents per share. The company also saw revenues of $920.9 million, which beat our estimate of $878.3 million. That revenue figure represents growth of 25% on a year-over-year basis, and Endo also affirmed its full-year guidance. Shares of ENDP gained over 22% in morning trading.
Bottom Line
For those who follow the Zacks Industry Rank, these earnings results will come as no surprise. Across the board, medical related industries have been impressive recently. Investors should continue to check out these sectors for other stocks that could post big gains.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>